High Growth Tech Stocks To Explore In The UK June 2025

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index declining due to weak trade data from China, highlighting broader concerns about global economic recovery and its impact on UK companies closely tied to international markets. In such a fluctuating environment, identifying high-growth tech stocks that can navigate these uncertainties becomes crucial for investors seeking opportunities in the UK's dynamic technology sector.

Top 10 High Growth Tech Companies In The United Kingdom

Name	Revenue Growth	Earnings Growth	Growth Rating
ENGAGE XR Holdings	22.08%	84.46%	★★★★★★
Audioboom Group	8.84%	59.33%	★★★★★☆
YouGov	3.98%	64.42%	★★★★★☆
Redcentric	5.32%	67.90%	★★★★★☆
Oxford Biomedica	16.89%	80.47%	★★★★★☆
Windar Photonics	37.17%	46.73%	★★★★★☆
Trustpilot Group	15.02%	40.20%	★★★★★☆
Quantum Base Holdings	132.55%	92.87%	★★★★★☆
Faron Pharmaceuticals Oy	55.41%	54.99%	★★★★★☆
Cordel Group	33.50%	148.58%	★★★★★☆

Click here to see the full list of 41 stocks from our UK High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Faron Pharmaceuticals Oy (AIM:FARN)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Faron Pharmaceuticals Oy is a clinical stage drug discovery and development company with a market cap of £279.45 million.

Operations: The company focuses on drug discovery and development, operating at the clinical stage with a market capitalization of £279.45 million.

Faron Pharmaceuticals Oy, a trailblazer in the biotech landscape, recently showcased compelling phase II data at the ASCO Annual Meeting, highlighting a 56% composite CR rate with its bexmarilimab treatment in HR-MDS—significantly surpassing historical rates of 20-25% with azacitidine alone. This pivotal data paves the way for a confirmatory trial that could redefine standards for HR-MDS treatment. Moreover, Faron's strategic focus on R&D is evidenced by its robust pipeline and recent promising results published in Lancet Haematology and Scientific Reports, underscoring bexmarilimab's potential against AML and MDS. With an annualized revenue growth forecast at 55.4%, Faron is not just advancing medical science but also outpacing typical market growth rates significantly.

• Unlock comprehensive insights into our analysis of Faron Pharmaceuticals Oy stock in this health report.

• Explore historical data to track Faron Pharmaceuticals Oy's performance over time in our Past section.

M&C Saatchi (AIM:SAA)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: M&C Saatchi plc is a global advertising and marketing communications company operating across the United Kingdom, Europe, the Middle East, the Asia Pacific, and the Americas with a market cap of £213.33 million.

Operations: The company generates revenue primarily through its advertising and marketing communications services across various regions, including the UK, Europe, the Middle East, Asia Pacific, and the Americas. Its financial performance is highlighted by a focus on managing costs effectively to sustain profitability.

M&C Saatchi, transitioning from a challenging period with a net loss in previous years to reporting a profit of £14.73 million for 2024, illustrates resilience in the volatile advertising sector. This turnaround is marked by an earnings growth forecast of 25.2% annually, surpassing the UK market's average of 14.5%. Despite anticipated revenue contraction at -15% annually over the next three years, strategic board changes and dividend increases signal confidence in sustainable growth and governance strength. These elements suggest M&C Saatchi is navigating its recovery phase with robust measures to stabilize and potentially enhance shareholder value amidst industry shifts.

• Take a closer look at M&C Saatchi's potential here in our health report.

• Learn about M&C Saatchi's historical performance.

Pinewood Technologies Group (LSE:PINE)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pinewood Technologies Group PLC is a cloud-based dealer management software provider with operations in the United Kingdom, Europe, Africa, Asia, the Middle East, and other international markets; it has a market capitalization of £401.64 million.

Operations: Pinewood Technologies Group focuses on providing cloud-based dealer management software across multiple regions. The company leverages its technological solutions to support automotive dealerships in streamlining their operations and enhancing customer interactions.

Pinewood Technologies Group PLC, a key player in automotive software solutions, recently secured a landmark five-year contract with Volkswagen Group Japan to deploy its Pinewood Automotive Intelligence platform across approximately 350 dealerships. This strategic move not only broadens Pinewood's international footprint but also aligns with its ambitious growth targets. Financially, the company reported robust earnings for the eleven months ending December 2024, with sales reaching £31.2 million and net income at £5.7 million. These figures underscore a significant upward trajectory in both revenue and earnings, projected to grow annually by 25% and 42.2%, respectively—outpacing the UK market averages significantly. This performance is particularly noteworthy given the context of their recent large one-off loss of £2.4M, highlighting their resilience and potential for sustained growth despite past volatility.

• Dive into the specifics of Pinewood Technologies Group here with our thorough health report.

• Review our historical performance report to gain insights into Pinewood Technologies Group's's past performance.

Summing It All Up

• Discover the full array of 41 UK High Growth Tech and AI Stocks right here.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com